Centhaquine

Centhaquine

SCHEMBL29991817

Cc1cccc(N2CCN(CCc3ccc4ccccc4n3)CC2)c1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 7/20 0.58
HTR1A P08908 5/20 0.58
HTR2A P28223 4/20 0.58
HTR2C P28335 4/20 0.58
KCNH2 Q12809 7/20 0.56
ADRA1A P35348 3/20 0.48
SLC6A4 P31645 2/20 0.48
ADRA2A P08913 1/20 0.48
CHRM1 P11229 1/20 0.48
DRD1 P21728 1/20 0.48
OPRM1 P35372 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HRH1 P35367 1/20 0.47
HTR7 P34969 2/20 0.46
DRD2 P14416 4/20 0.46
ADRA1D P25100 1/20 0.44
ADRA1B P35368 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Centhaquine SCHEMBL10029638 1.00 DRD3 (0.58) DRD3HTR1AHTR2AHTR2CKCNH2
Centhaquine SCHEMBL29751033 1.00 DRD3 (0.58) DRD3HTR1AHTR2AHTR2CKCNH2
Centhaquine SCHEMBL11788684 0.99 DRD3 (0.57) DRD3HTR1AHTR2AHTR2CKCNH2
SCHEMBL8323587 0.88 HTR1A (0.55) DRD3HTR1AHTR2AHTR2CKCNH2
Centhaquine SCHEMBL29991187 0.87 DRD3 (0.56) DRD3HTR1AHTR2AHTR2CKCNH2
SCHEMBL11786229 0.86 MAPT (0.59) DRD3HTR1AHTR2AHTR2CADRA1A
SCHEMBL11785894 0.86 DRD2 (0.56) DRD3HTR1AHTR2AHTR2CKCNH2
SCHEMBL27590575 0.86 HTR1A (0.60) DRD3HTR1AHTR2AHTR2CKCNH2
SCHEMBL11786467 0.86 DRD3 (0.48) DRD3HTR1AHTR2AHTR2CKCNH2
SCHEMBL11784684 0.86 SIGMAR1 (0.62) DRD3HTR1AKCNH2ADRA1ASLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337209-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN CORONA VIRUS DISEASE (COVID-19) Pharmazz, Inc. (US) 2024-03-20 EP disclosed
CN-117440812-A Pharmaceutical compositions and methods for treating Acute Respiratory Distress Syndrome (ARDS) in coronavirus disease (covd-19) 法尔麦兹公司 2024-01-23 CN disclosed
WO-2022240964-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN CORONA VIRUS DISEASE (COVID-19) PHARMAZZ, INC. (US) 2022-11-17 WO disclosed